Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
06/2010
06/29/2010US7745216 Methods and reagents for treating glucose metabolic disorders
06/29/2010US7745215 Methods and compositions for expanding T regulatory cells
06/29/2010US7745214 for assessing the effect of candidate chemotherapeutic drugs on the growth of brain tumors; fibroblast growth factor expressing cells and diagnosis and treatment of tumors; antiproliferative agents
06/29/2010US7745213 nucleotide sequences coding potassium chanel protein for use in identifying modulator for prevention and treatment of cardiovascular/myocardial disorders; utilized to diagnose and screen for short QT syndrome, long QT syndrome, Brugada syndrome and progressive conduction disease
06/29/2010US7745212 Melanoma antigens and their use in diagnostic and therapeutic methods
06/29/2010US7745188 Heat resistant and error-prone polymerase for use as mutational tool in genetic analysis
06/29/2010US7745179 Lentiviral producer cell; such as mounse transthyretin (mTTR) promoter (antibody); recombinant lentiviruses and transfer vectors for transgene delivery and gene therapy; blood coagulation factor IX; antihemopohilic factor
06/29/2010US7745174 co-expressing two heterotypes of Hepatocyte Growth Factor (HGF) comprising transforming or transfecting to a cell a DNA construct; for prevention and treatment of ischemic and liver disorders
06/29/2010US7745140 Cell proliferation; tissue engineering; screening, detection of antigens; immunitherapy; development of vaccine; antitumor, anticancer agents
06/29/2010US7745120 Cell culture and method for screening for a compound useful in the treatment or prevention of hepatic cirrhosis
06/29/2010US7745113 in vitro methods of expansion and propagation of undifferentiated progenitor cells containing Islet1, a marker unique to proliferating cardiac stem cells; done without differentiation to provide cardiac repair or improve cardiac function
06/29/2010US7744927 Methods of promoting hematopoietic and mesenchymal cell proliferation and differentiation
06/29/2010US7744912 Forming a biopolymer by polymerization or crosslinking through self-selective reaction between a strong multifunctional nucleophile such as amine or thiol and a conjugated unsaturated bond; preparation of highly biomimetic synthetic polymers
06/29/2010US7744907 Ex vivo animal or challenge model as method to measure protective immunity directed against parasites and vaccines shown to be protective in the method
06/29/2010US7744903 Epitopes confirmed to be recognized by T-cells derived from herpetic lesions or uterine cervix; vaccination; host cells
06/29/2010US7744897 Human immunodeficiency virus gp41 mimetibody polypeptides
06/29/2010US7744896 therapeutic vaccine anti-HIV, anti-AIDS and against tumors and syndromes associated with HIV infection
06/29/2010US7744886 Methods for interfering with rank signaling
06/29/2010US7744881 for cancer treatment by inducing apoptosis; monoclonal antibodies; drug conjugated with polyoxyethylene glycol or enzyme or radioisotope, fluorescent compound or chemiluminescent compound; genetic engineering; biodrugs; anticarcinogenic agents
06/29/2010US7744878 Antibodies that bind to cancer-associated antigen CD46 and methods of use thereof
06/29/2010US7744869 Modulating mesenchymal stem cell activity electrical stimulation; regenerative medicine; tissue engineering; bone morphogenic protein-2 (BMP-2)
06/29/2010US7744526 Bioreactor for the manufacture of tissue engineered blood vessels
06/29/2010CA2482747C Vaccine composition for preventing meningococcal disease
06/29/2010CA2428158C Methods for isolating novel antimicrobial agents from hypermutable mammalian cells
06/29/2010CA2390082C Novel hcv non-structural polypeptide
06/29/2010CA2379734C Treatment of cancers
06/29/2010CA2370477C Recombinant protein production in a human cell using sequences encoding adenovirus e1 protein
06/29/2010CA2358439C Metastasis models using green fluorescent protein (gfp) as a marker
06/29/2010CA2274498C Novel expression vectors containing accessory molecule ligand genes and their use for immunomodulation and treatment of malignancies and autoimmune disease
06/29/2010CA2252372C Pathogenic escherichia coli associated protein
06/29/2010CA2251560C Pesticidal toxins
06/29/2010CA2218909C Isolating and culturing schwann cells
06/29/2010CA2187740C Dna encoding bradykinin b1 receptor
06/29/2010CA2163976C Methods and compositions for inhibiting cd14 mediated cell activation
06/24/2010WO2010071889A1 Use of fetal cells for the treatment of genetic diseases
06/24/2010WO2010071864A1 Treatment of lung and pulmonary diseases and disorders
06/24/2010WO2010071863A1 Regeneration and repair of neural tissue following injury
06/24/2010WO2010071862A1 Umbilical cord tissue derived cells for treating neuropathic pain and spasticity
06/24/2010WO2010071800A1 Feed supplement for mammalian cell culture and methods of use
06/24/2010WO2010071692A2 Methods for enhanced propagation of cells
06/24/2010WO2010071210A1 Chondrocyte-like cell, and method for producing same
06/24/2010WO2010070877A1 Elovl7 epitope peptides and vaccines containing the same
06/24/2010WO2010070620A1 Erythrocyte-based delivery system, method of preparation and uses thereof
06/24/2010WO2010070342A1 Improvements in or relating to growing cells
06/24/2010WO2010070105A1 Pharmaceutical preparation
06/24/2010WO2010070047A1 Soluble polypeptides for use in treating autoimmune and inflammatory disorders
06/24/2010WO2010069589A1 Cell transport system
06/24/2010WO2010069204A1 Pluripotent stem cells, method for preparation thereof and uses thereof
06/24/2010WO2010069008A1 A germline competent cell derived from adult tissue
06/24/2010WO2010068978A1 Methods of modulating the sex of avians
06/24/2010WO2010046519A9 Animal model of human angiogenesis and applications thereof
06/24/2010WO2010045389A4 Method and apparatus for increasing adipose vascular fraction
06/24/2010WO2010040804A3 Methods for controlled seeding of adherent cell types on high density patterned cell cultures
06/24/2010WO2010028019A3 Direct reprogramming of somatic cells using non-integrating vectors
06/24/2010WO2010027789A3 Volume exclusion agent to enhance formation of extracelluar matrix
06/24/2010US20100162443 Promoters for regulation of gene expression in plant roots
06/24/2010US20100162441 Plants Having Improved Growth Characteristics And Method For Making The Same
06/24/2010US20100162440 Method for Optimization of Transgenic Efficacy Using Favorable Allele Variants
06/24/2010US20100162439 Pesticidal genes from brevibacillus and methods for their use
06/24/2010US20100162437 Functional r-gene from solanum bulbocastanum
06/24/2010US20100162436 Site-specific integration and stacking of transgenes in soybean via dna recombinase mediated cassette exchange
06/24/2010US20100162435 Transgenic plants; seeds, oils, foods and animal feeds
06/24/2010US20100162433 Plants with improved nitrogen utilization and stress tolerance
06/24/2010US20100162432 Plant cells and plants with increased tolerance and/or resistance to environmental stress and increased biomass production-ko
06/24/2010US20100162430 Nutritionally Enhanced Inbred Maize Line HHA612ND
06/24/2010US20100162429 Nutritionally Enhanced Inbred Maize Line HHA601ND
06/24/2010US20100162427 Polynucleotides and polypeptides in plants
06/24/2010US20100162421 Use of pleitrophin for preventing and treating pancreatic diseases and/or obesity and/or metabolic syndrome
06/24/2010US20100162419 Tumor-initiating cells and methods of use
06/24/2010US20100162418 Recombinant protein s composition
06/24/2010US20100162416 Multi-stage stem cell carcinogenesis
06/24/2010US20100162415 Transgenic mice expressing humanized vegf
06/24/2010US20100160420 Novel simian t-cell lymphotropic virus
06/24/2010US20100160417 Chromosome Therapy
06/24/2010US20100160416 Use of pol iii promoters for controlled expression of therapeutic proteins
06/24/2010US20100160355 Anti-Viral Compounds
06/24/2010US20100160350 Pyrazolopyrimidinone kinase inhibitor
06/24/2010US20100160348 Materials and methods for detecting and treating peritoneal ovarian tumor dissemination involving tissue transglutaminase
06/24/2010US20100160292 Kinase Inhibitors, and Methods of Using and Identifying Kinase Inhibitors
06/24/2010US20100160287 Compounds useful as inhibitors of janus kinases
06/24/2010US20100160261 Polyunsaturated fatty acid monoglycerides, derivatives, and uses thereof
06/24/2010US20100160235 Fgf homologs compositions and uses thereof
06/24/2010US20100160227 Signaling peptides
06/24/2010US20100160225 Lefty, lefty derivatives and uses thereof
06/24/2010US20100160221 Effect of tula on hiv
06/24/2010US20100160217 Acetylycholine gated ion channel chaperons and methods of using the same
06/24/2010US20100160210 Guanidinium delivery carriers
06/24/2010US20100160183 Inkjet gene printing
06/24/2010US20100159598 In Vitro Methods for the Induction and Maintenance of Plant Cell Lines as Single Suspension Cells With Intact Cell Walls, and Transformation Thereof
06/24/2010US20100159597 Cell culture membrane, cell culture kit, porous material, production method for cell culture membrane and production method for porous material
06/24/2010US20100159596 Small molecule compounds for stem cell differentiation
06/24/2010US20100159595 Method of generating myelinating oligodendrocytes
06/24/2010US20100159594 Single chain trimers and uses therefor
06/24/2010US20100159593 Transfection reagents
06/24/2010US20100159592 Emulsion compositions
06/24/2010US20100159591 METHODS AND COMPOSITIONS CONCERNING siRNA'S AS MEDIATORS OF RNA INTERFERENCE
06/24/2010US20100159590 Systems and methods for active microfluidic cell handling
06/24/2010US20100159589 Nestin-expressing hair follicle stem cells
06/24/2010US20100159588 Conditioned media and methods of making a conditioned media
06/24/2010US20100159587 Antibodies against human angiopoietin 2